GOOD’S SYNDROME WITH INCREASING γδ T-LYMPHOCYTE SUBPOPULATION: CASE REPORT

  • Dragana Tadić Clinical-Hospital Center "Bezanijska kosa" Belgrade
  • Dragana Tadić Clinical-Hospital Center "Bezanijska kosa" Belgrade
  • Olivera Marković Clinical-Hospital Center "Bezanijska kosa" Belgrade
  • Nada Kraguljac-Kurtović Clinic of Hrmatology, Clinical Center of Serbia
  • Nada Kraguljac-Kurtović Clinic of Hrmatology, Clinical Center of Serbia
  • Olika Drobnjak Clinical-Hospital Center "Bezanijska kosa" Belgrade
  • Olika Drobnjak Clinical-Hospital Center "Bezanijska kosa" Belgrade

Abstract


Background: Good’s syndrome is a rare cause of adult-onset immunodeficiency associated with thymoma.

Case report: We present 56-year-old men in whom Good’s syndrome has been diagnosed after two-year history recurrent infections. Examination of immune status of patient showed decreased serum levels of all immunoglobulins. Flow cytometry of peripheral blood lymphocyte revealed markedly reduced of peripheral B cells, CD4 T-cell lymphopenia, inverted CD4/CD8 T cell ratio 0,37 (CD4 20.82%, CD8 70.7%). Analysis of the subpopulations of T lymphocytes showed relative increasing of γδTCR T lymphocytes. Computed tomography scan of the chest showed a mediastinal mass compatible with thymoma diameter of 40mm. After initiation of intravenous immunoglobulins the patient is in the good clinical condition and without bacterial complications. As the patient refused the operative treatment we continue to control the mediastinal tumor mass which did not increase during the three-year follow-up.

Conclusion: Good’s syndrome should be considered in patients older than 40 years with history of frequent infections. An abnormal immunoglobulin profile needs further investigation and flow cytometry which is crucial for establishing the diagnosis of Good’s syndrome. Our patient had typical immunological finding for Good’s syndrome, but also an increase of γδ TCR T lymphocyte subpopulation for which it is difficult to determine whether this is pathogenetic or secondary reactive event.

 

Uvod: Good-ov sindrom je redak oblik imunodeficijencije kod odraslih udružene sa timomom.

Prikaz bolesnika: Mi prikazujemo bolesnika starosti 56-godina kod koga je postavljena dijagnoza Good-ovog sindroma posle dvogodišnjeg perioda ponavljanih infekcija. Imajući u vidu smanjen nivo svih imunoglobulina u serumu uradjena je protočna citometrija limfocita periferne krvi. Ovom metodom utvrdjeno je potpuno odsustvo B ćelija, CD4 limfopenija, inverzan odnos CD4/CD8 T ćelija - 0,37 (CD4 20.82%, CD8 70,7%). Analiza subpopulacija T limfocita pokazala je relativno povećanje γδTCR T limfocita. CT pregledom grudnog koša vidjena je medijastinalna tumorska masa koja odgovara timomu prečnika 40mm. Posle započinjanja lečenja mesečnom primenom intravenskih imunoglobulina došlo je do značajne redukcije infektivnih komplikacija. S obzirom da je pacijent odbio operativno lečenje nastavljeno je CT praćenje medijastinalne tumorske mase koja se nije povećala tokom trogodišnjeg perioda.

Zaključak: Na Good-ov sindrom treba misliti kod bolesnika starijih od 40 godina sa istorijom čestih infekcija. Smanjenje koncentracije imumoglobulina u serumu zahteva dalje ispitivanje uključujući protočnu citometriju koja je od ključnog značaja za postavljanje dijagnoze Good-ovog sindroma. Kod našeg bolesnika je protočnom citometrijom utvrdjen je nalaz tipičan za Good-ov sindroma, ali je registrovano i povećanje subpopulacije γδ TCR T limfocita za koje nije jasno da li je patogenetski ili reaktivni događaj.

 

Author Biography

Olivera Marković, Clinical-Hospital Center "Bezanijska kosa" Belgrade
Department of Hematology

References

Kelleher P, Misbah SA. What is Good's syndrome?: immunological abnormalities in patients with thymoma. J Clin Pathol 2003; 56:12-16.

Good RA. A gammaglobulinemia: a provocative experiment of nature. Bull Uni Minnesota Hosp Minn Med Foundation 1954, 26:1-19.

Tarr PE, Sneller MC, Mechanic LJ, et al. Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine 2001; 80:123–33

Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2011; 2:54-6.

Watts RG, Kelly DR. Fatal varicella infection in a child associated with thymoma and immunodeficiency (Good's syndrome) Medical and Pediatric Oncology 1990, 18(3):246–51.

Blore J, Haeney MR. Primary antibody deficiency and diagnostic delay. BMJ1989; 298:516–7.

Oritani K, Medina KL, Tomiyama Y, et al. Limitin: an interferon-like cytokine that preferentially influences B-lymphocte precursors. Nat Med Immunbol 2000, 3:659-66.

Raschal S, Sigel JN, Huml J, Richmond GW. Hypogammaglobulinemia and anemia 18 years after thymoma resection. J Allergy Clin Immunol 1997; 100:846-48.

Kelesidis T, Yang O. Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence. Clinical immunology 2010, 135(3):347-63.

Haas W, Pereira P, Tonegawa S: Gamma/delta cells. Annu Rev Immunol 1993; 11:637-45.

Leiva LE, Junprasert J, Hollenbaugh D, Sorensen U. Central Nervous System Toxoplasmosis with an Increased proportion of Circultating γδ T cells in patient with Hyper-IgM Syndrome. Journal Clin Immunol 1998, 18(4):283-90.

Katial RK, Lieberman MM, Muehlbauer SL, Lust JA, Hamilos DL: Gamma/delta T lymphocytosis associated with common variable immunodeficiency. J Clin Immunol 1997, 17:34-42.

Lee SH, Lee SM, Yang SC, Yoo CG, Kim YW, Shim YS and Han KS. A case of granulomatous lung disease in a patient with Good's syndrome. Korean J Intern Med 2008; 23(4):219-22.

Ide S, Koga T, Rikimaru T, et al. Good’s syndome presenting with cytomegalovirus pneumonia. Intern Med 2000, 39:1094-6.

Jian L, Bin D, Haiyun W. Fatal Pneumocystis Pneumonia with Good Syndrome and Pure Red Cell Aplasia. Clinical Infectious Diseases 2004; 39(11):1740-1.

Raschou-Jensen K, Katzenstein TL, Marquart H, Ryder L, Daugaard G. Diagnostic Dilemma: Lymphocytopenia in a Patient with Thymoma – Side Effect due to Irradiation Treatment or Development of Good's Syndrome? Case Rep Oncol. 2010; 3(2):240-4.

Johnson SB, Eng TY, Giaconne G, et al. Thymoma: update for the new millennium. The Oncologist 2001; 6:239-46.

Kitamura A, Takiguchi Y, Tochigi N, Watanabe S, Sakao S, Kurosu K, et al. Durable Hypogammaglobulinemia Associated with Thymoma (Good Syndrome). Inter Med 48:1749-52.

Agarwal S, Cunningham CC. Thymoma and immunodeficiency (Good syndrome): a report of 2 unusual cases and review of the literature. Ann Allergy Asthma Immunol 2007 98(2):185-90.

Ohuchi M, Inoune S, Igarashi T, et. al. Good Syndrome Coexisting With Leukopenia. Ann Thorac Surg. 2007; 84: 2095-7.

Oshikiri T, Morikawa T, Sugiura H, Katoh H. Tymoma associated with hypogammaglobulinemia (Good’s syndrome): report of a case. Surg Today 2002, 32:264-6.

Published
2015/11/02
Section
Case report